Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

NCT00225121

Conditions: Neoplasms
Locations: Ronald Reagan UCLA Medical Center Los Angeles, California, United States

UCLA Hematology/Oncology Los Angeles, California, United States

UCLA Oncology Center Los Angeles, California, United States

UCLA Hematology Oncology - Santa Monica Santa Monica, California, United States

View Trial Details

Completed

Monotherapy Dose Finding With BI 847325 in Solid Tumours

NCT01324830

Conditions: Neoplasms
Locations: 1287.1.3201 Boehringer Ingelheim Investigational Site Brussels, Belgium

1287.1.3202 Boehringer Ingelheim Investigational Site Leuven, Belgium

View Trial Details

Completed

Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks

NCT03336489

Conditions: Neoplasms, Nervous System Diseases, Neurodegenerative Diseases, +1 more
Locations: Reseau QUIETUDE Paris, France

Reseaux ROPE Paris, France

Reseau ENSEMBLE Paris, France

Reseaux ParisOuest Paris, France

View Trial Details

Completed

Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

NCT00578630

Conditions: Neoplasms
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors

NCT00940498

Conditions: Neoplasms
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Insitute Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

BAY86-9766 Plus Gemcitabine Phase I Study in Asian

NCT01764828

Conditions: Neoplasms
Locations: Shanghai, China

Kashiwa, Chiba, Japan

Seoul, South Korea

View Trial Details

Completed

Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study

NCT02636426

Conditions: Neoplasms
Locations: VU University Medical Center Amsterdam, North Holland, Netherlands

View Trial Details

Completed

An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas

NCT01240577

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Alberta Cancer Exercise Pilot Randomized Trial

NCT02330575

Conditions: Neoplasms
Locations: University of Calgary/ Tom Baker Cancer Centre Calgary, Alberta, Canada

University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Completed

A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT01688206

Conditions: Neoplasms
Locations: Cliniques Universitaires St-Luc Brussels, Belgium

UZ Leuven Gasthuisberg Leuven, Belgium

Institut Bergonie; Oncologie Bordeaux, France

Centre Francois Baclesse; Oncologie Caen, France

View all 14 locations

View Trial Details